Back to Search
ROBERT RODEN, PH.D.
PH.D.
Clinical Psychologist
NPI: 1780641647Individual
Specialties, Licenses & Credentials
Clinical PsychologistPrimary
Psychologist — Clinical
Code: 103TC0700X
1283(AZ)
Research & Publications (20)
Combination of proteasome and HDAC inhibitors for uterine cervical cancer treatment.
PMID 19147762·Clin Cancer Res·2009
7-preclinical
p53 autoantibodies, cytokine levels and ovarian carcinogenesis.
PMID 19398128·Gynecol Oncol·2009
8-other
Expression pattern and subcellular localization of human papillomavirus minor capsid protein L2.
PMID 19095951·Am J Pathol·2009
8-other
Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer.
PMID 19619303·BMC Cancer·2009
8-other
CalDAG-GEFI is at the nexus of calcium-dependent platelet activation.
PMID 19628710·Blood·2009
7-preclinical
Self assembly of coiled-coil peptide-porphyrin complexes.
PMID 19374349·Biomacromolecules·2009
8-other
Tissue-spanning redox gradient-dependent assembly of native human papillomavirus type 16 virions.
PMID 19656879·J Virol·2009
8-other
Vaccination with HPV16 L2E6E7 fusion protein in GPI-0100 adjuvant elicits protective humoral and cell-mediated immunity.
PMID 19095032·Vaccine·2009
7-preclinical
Chimeric L1-L2 virus-like particles as potential broad-spectrum human papillomavirus vaccines.
PMID 19640991·J Virol·2009
7-preclinical
Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines.
PMID 19470949·J Natl Cancer Inst·2009
4-observational
R93W mutation in Orai1 causes impaired calcium influx in platelets.
PMID 18952890·Blood·2009
7-preclinical
Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2.
PMID 18413606·Proc Natl Acad Sci U S A·2008
7-preclinical
Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis.
PMID 18395030·Am J Obstet Gynecol·2008
6-review
Generation and characterization of a preventive and therapeutic HPV DNA vaccine.
PMID 18096279·Vaccine·2008
7-preclinical
Towards global prevention of human papillomavirus-induced cancer.
PMID 18228245·Eur J Immunol·2008
6-review
Mechanisms of human papillomavirus type 16 neutralization by l2 cross-neutralizing and l1 type-specific antibodies.
PMID 18305047·J Virol·2008
8-other
Antigen-specific immunotherapy of cervical and ovarian cancer.
PMID 18363994·Immunol Rev·2008
6-review
Ubiquitin proteasome system stress underlies synergistic killing of ovarian cancer cells by bortezomib and a novel HDAC6 inhibitor.
PMID 19010849·Clin Cancer Res·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1257 W WARNER RD, SUITE B-3
CHANDLER, AZ 85224 - Phone
- (480) 899-8474
Quick Facts
- NPI
- 1780641647
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile